Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036412 · ClinicalTrials.gov registry record · Phase 1
Chlorhexidine Gel Therapy for Cariogenic Oral Microflora
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01036412: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT01036412 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01036412, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if 1% chlorhexidine gluconate gel will decrease the amount of bacteria that causes tooth decay. Whether the gel is acceptable to patients will also be studied.
Interventions
- BEHAVIORAL Surveys
- DRUG 1% Chlorhexidine Gluconate Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01036412
The ClinicalTrials.gov registry entry for NCT01036412 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Surveys is the first listed.
NCT01036412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01036412 about?
NCT01036412 is a clinical study titled "Chlorhexidine Gel Therapy for Cariogenic Oral Microflora". The goal of this clinical research study is to find out if 1% chlorhexidine gluconate gel will decrease the amount of bacteria that causes tooth decay. Whether the gel is acceptable to patients will also be studied.
What is the current status of trial NCT01036412?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2009-12. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01036412?
The interventions under investigation include: Surveys (BEHAVIORAL), 1% Chlorhexidine Gluconate Gel (DRUG).
Who is sponsoring clinical trial NCT01036412?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.